U.S. Food and Drug Administration
RSB Spine, LLC, Announces Additional FDA Clearance for the InterPlate(R) L-Ti
Published in Medical Letter on the CDC and FDA, October 3rd, 2010
RSB Spine Chief Executive Officer John A. Redmond said: "We are excited about this new clearance. Because of our Bridging Flush Fit™ design, we have always been of the opinion that the InterPlate L-Ti can function as an interbody fusion device and/or anterior lumbar plate. The new product code also simplifies coding surgeons, clarifying reimbursement for this type of zero profile implant."
RSB Spine is a privately held medical device company focused on developing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Inspire Pharmaceuticals, Inc.
Data to Be Presented at ERS Conference Highlights Potential for Denufosol to Benefit Cystic Fibrosis Patients on Minimal Pharmacotherapy - U.S. Food and Drug Administration
FDA, U. of Md. Train Bangladeshis on Aquaculture Safety - Agriculture and Food Chemistry
Studies by S. Hennessy and co-authors describe new findings in agriculture and food chemistry - Anthrax
Study results from Center for Biologics Evaluation and Research provide new insights into anthrax - Beyond Pesticides
Bed Bugs Can Be Controlled Without Toxic Pesticides - Biologics
Compendia Usage and Off-Label Indications Focus of NCCN Oncology Summit - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
